Impact of Timing of PD Assessments on Measures of Platelet Reactivity in Patients Undergoing PCI Treated With Cangrelor
CompletedOBSERVATIONAL
Enrollment
17
Participants
Timeline
Start Date
January 28, 2021
Primary Completion Date
April 4, 2021
Study Completion Date
July 20, 2021
Conditions
Coronary Artery Disease
Trial Locations (1)
32209
University of Florida, Jacksonville
All Listed Sponsors
collaborator
Chiesi Farmaceutici S.p.A.
INDUSTRY
lead
University of Florida
OTHER
NCT04668495 - Impact of Timing of PD Assessments on Measures of Platelet Reactivity in Patients Undergoing PCI Treated With Cangrelor | Biotech Hunter | Biotech Hunter